Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2017-09-13 2017-09-13
Drug Identification Number 02239194 02239194
Brand name HEPTOVIR HEPTOVIR
Common or Proper name lamivudine oral solution lamivudine oral solution
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients LAMIVUDINE LAMIVUDINE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL
Packaging size 240 mL 240 mL
ATC code J05AF J05AF
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-02 2017-08-02
Estimated end date 2017-09-22 2017-09-22
Actual end date 2017-09-12 2017-09-12
Shortage status Resolved Resolved
Company comments
Health Canada comments